Evaluation of Risk Factors Affiliated with Age Related Macular Degeneration
Article Sidebar
Main Article Content
Abstract
Objective - The research aimed to evaluate the risk factors affiliated with ARMD.
Materials & Method - The research used a cross sectional design, elderly patients of 50 years age group. All the eligible patients were assessed on the basis occupation, h/o smoking, diabetes, hypertension, obesity & pigment abnormalities by performing External examination with torchlight, Snellen’s chart for visual acuity, Slit lamp bio-microscopy, Amsler grid, Fundus Examination with Direct ophthalmoscope, 90 D and indirect-ophthalmoscope after full dilatation, Optical coherence tomography.
Results - In this research it was observed that ARMD was much higher in housewives (34 %) and shopkeepers (12%) were most affected. History of smoking (42%) was calculated to be less associated with the patients of ARMD. Majority patients presented with intermediate drusens on fundus finding followed by large (20%), geographical atrophy (18%), CNVM (11%) and few small drusens (11%). Dry (NON-EXUDATIVE) ARMD (89%) was seen higher than WET(EXUDATIVE) ARMD (11%). The amount of obesity and ARMD had very less significance (40%). History of diabetes (75%) and hypertension (69%) were found to have strong association.
Conclusion - The results revealed that history of smoking had higher odds to exhibit ARMD, in comparison to diabetes, hypertension and obesity.
Article Details
References
Klein R, Klein BE, Cruickshanks KJ. The Prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res; 1999; 18: 371–89.
Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study Ophthalmology; 1995; 102: 1450–60.
Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci; 2001; 42: 2237–41.
Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology; 2010; 117: 921–27.
Wong TY, Chakravarthy U, Klein R, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology; 2008; 115: 116–26.
Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA; 2004; 291: 1900–01.
Bressler NM, Doan QV, Varma R, et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch Ophthalmol; 2011; 129: 709–17.
Klein R, Klein BE, Knudtson MD, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology; 2006; 113: 373–80.
Klein RKlein BETomany SCMoss SE Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol; 2002; 156 (7)
Snow KKSeddon JM Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol; 1999; 6 (2)
Tomany SCWang JJvan Leeuwen R et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology; 2004; 111 (7)
Hyman, LSchachat, APHe, QLeske MC. Age-Related Macular Degeneration Risk Factors Study Group, Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol; 2000; 118 (3)
Klein, RKlein, BEKTomany, SCCruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology; 2003; 110 (6)
Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N EnglJ Med; 2000; 342 (7): 483-92.
Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular, Department of Ophthalmology and Visual Sciences, The University of Iowa Center for Macular Degeneration, USA.
Sucheta R Kulkarni, Supriya R Aghashe, Rajiv B Khandekar, Madan D Deshpande. Prevalence and determinants of age-related macular degeneration in the 50 years and older population: A hospital based study in Maharashtra, India: Indian J Ophthalmol; 2013 May; 61 (5): 196–201.
Pokharel S, Malla OK, Pradhananga CL, Joshi SN. A Pattern of Age-related Macular Degeneration: Department of Ophthalmology, Kathmandu Medical College, Department of Ophthalmology, Institute of Medicine, Maharaj- gunj, Kathmandu, Nepal J Nepal Med Assoc; 2009; 48 (175): 217-20.
L A Goold, K Edussuriya, S Sennanayake, T Senaratne D Selva,T R Sullivan, R J Casson, BMJ. Prevalence and determinants of age-related macular degeneration in central Sri Lanka: the Kandy Eye Study; 2010.
R. Klein, B.E. K. Klein, M.D. Knudtson, S.M. Meuer, S.M. Meuer R. The Fifteen–Year Incidence of Age–Related Macular Degeneration: The Beaver Dam Eye Study, Investigative Ophthalmology & Visual Science, Vol.47. Gangnon: May 2006. 1129.
Paul Mitchell, MD, PhD; Jie Jin Wang, MMed, PhD; Wayne Smith, MBBS, PhD; et al Stephen R. Leeder MBBS, PhD. Smoking and the 5-Year Incidence of Age-Related Maculopathy: The Blue Mountains Eye Study, Arch Ophthalmol; 2002.
Praveen K, Nirmalan, MD, MPH; Joanne Katz, PhD; Alan L. Robin, MD; et al James M. Tielsch, PhD; Perumalsamy Namperumalsamy, MD; Ramasamy Kim, MD; V. Narendran, MD; Rengappa Ramakrishnan, MD; Ramasamy Krishnadas, MD; Ravilla D. Thulasiraj, MBA; Eric Suan, MD. Prevalence of Vitreoretinal Disorders in a Rural Population of Southern India: The Aravind Comprehensive Eye Study, Arch Ophthalmol; 2004;122 (4): 581-586.
Sannapaneni Krishnaiah, Taraprasad Das, Praveen K. Nirmalan, ishita Nutheti, Bindiganavale R. Shamanna, Gullapalli N. Rao, Ravi Thomas. Risk Factors for Age-Related Macular Degeneration: Findings from the Andhra Pradesh Eye Disease Study, Investigative Ophthalmology & Visual Science, Vol.46. South India: December 2005, 4442-4449.
Augood CF letcher, A Bentham G et al. Methods for a population-based study of the prevalence of age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study: Ophthalmic Epidemiol; 2006.
AREDS2 Research Group. “Lutein/Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Controlled Randomized Clinical Trial.” JAMA, published online May.